Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

about

MicroRNA-21 and Dicer are Dispensable for Hepatic Stellate Cell Activation and the Development of Liver Fibrosis.

P2860

Q46739942-DE85E968-ECC5-4204-9893-8F4B5474F6AF

P2860

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

Item

http://www.wikidata.org/entity/Q38644294

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

@en

type

Item

label

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

@en

prefLabel

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

@en

P1476

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

@en

P2093

Johan Holmberg

http://www.w3.org/2001/XMLSchema#string

Madeleine Durbeej

http://www.w3.org/2001/XMLSchema#string

P2860

Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.

IPython: A System for Interactive Scientific Computing

Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.

Animal models for muscular dystrophy: valuable tools for the development of therapies.

An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.

Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.

Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A

P304

e0181950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0181950

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bernardo Moreira Soares Oliveira

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28771630

http://www.w3.org/2001/XMLSchema#string

P932

5542641

http://www.w3.org/2001/XMLSchema#string

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

about

P2860

P2860

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932